Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/12/12 → 12/23/14 |
Funding
- Novartis Pharmaceuticals Corporation: $63,620.00
Protocol No: RLX030A2205; An Adaptive Multicenter, Randomized, Partially Double-Blind, Placebo-Controlled Study to Assess the Safety, PK and PD/efficacy of RLX030 in Women with Pre-Eclampsia
- Olson, Gayle (PI)
Project: Other project